Ignacio Sanchez, Ph.D. Email & Phone Number

Chicago, Il

I have just started this new consulting company after my recent retirement from Takeda Pharmaceuticals. You may reach me at the following email address: ignacio.sanchez@cpinnov.com or visit the company's web site (http://cpinnov.com) for additional information.

Deerfield, Il

Served as part of the US Operating Business Unit of Takeda Pharmaceuticals, inc., a $17 BN global company marketing class-leading products in over 70 countries around the world.Responsible for the global selection and project management of new CMOs for the manufacture of Early Phase pharmaceutical active materials (APIs) on a global basis. Responsible for drafting over 20 INDs and IMPDs for early phase drug substances. Responsible for managing all ADME-oriented radiolabeling activities, including vendor selection and manufacturing management for the early phase corporate projects. Over the past 10 years, I evaluated near 100 early Phase to commercial manufacturing projects and contributed to auditing numerous manufacturing facilities for technical suitability and cGMP compliance.Developed a modified sourcing strategy for an Alliance Partner product with potential for an overall 54% reduction in the manufacturing cost.Author/co-author of 44 peer-reviewed publications and holder of 14 US and/or international patents.

West Lafayette, In

This was a $27 MM start-up diagnostics and device company specializing in the design and manufacture of a novel BioCD-based diagnostic device for use in human and/or veterinary assays. For this purpose, I established a new state-of-the-art scale-up and manufacturing facility for novel, assay-based medical devices and designed new surface chemistries applicable to immunological assays.Directed and supervised the scale-up activities of the first disc-based, multiplexed human assays, as well as the scale-up and manufacturing of canine heart worm assays for veterinary diagnostics.Significantly reduced manufacturing costs through the selection of state-of-the-art manufacturing equipment and the creative use of process automation.

Denver, Co

Zettacore, Inc. was a $17 MM nanotechnology-based start-up company specializing in the design and manufacture of novel molecular electronics (moletronics) devices and related technologies used in molecular memory applications. I designed a new state-of-the-art, 20,000 ft2 R&D laboratory and manufacturing facilities, and oversaw the scale-up activities of the first porphyrin macrocycles-based project with potential commercial applications in electronic memory enhancement and management.Completed the construction and staffing of the Denver, CO R&D Center and Kilo Lab facilities.

Plymouth, In

I provided consulting services to emerging pharmaceutical and biotechnology companies in the South Bend, IN area regtarding cGMP pharmaceutical manufacturing readiness and FDA registration requirements.

Culver, In

Houba is a $5 MM manufacturing division (API and drug products) of Halsey Pharmaceuticals, Inc. I was noted for contributing $25+ MM in potential annual sales by devising the introduction of new pain management narcotics while demonstrating new manufacturing technologies in record time. Responsible also for managing a facility dedicated to the manufacture of Doxicyclin Hyclate API including solid phase drug product (tablets and capsules).

Various (See Below)

Additional ExperienceSiegfried CMS AG/Siegfried USA, Pennsville, NJ (200-2001); Director, Chemical Development, USA and Business Director, East Cost, USA.Great Lakes Chemical Corporation, Inc. West Lafayette, IN (1993-21000); General Manager/Business Director, Fine Chemicals and Director, Process Chemistry, USA

Doctor Of Philosophy (Ph.D.), Organic Chemistry, 3.88

Activities and Societies: Member, American Chemical Society Fellow, American Institute of Chemistry

M.Sc. Management, Business Administration And Management, General, 4.0

Bachelor Of Science (B.Sc.), Chemistry, 3.80 Summa Cum Laude

Postdoctoral Research, Natural Products Chemistry And Pharmacognosy

Activities and Societies: Natural products Research Center